TriSalus Life Sciences, Inc.
TLSI
$5.22
-$0.31-5.61%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -0.20% | 14.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.20% | 14.05% | |||
| Cost of Revenue | 10.09% | -6.08% | |||
| Gross Profit | -1.66% | 17.61% | |||
| SG&A Expenses | -8.40% | -11.97% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -7.67% | -14.35% | |||
| Operating Income | 14.40% | 30.05% | |||
| Income Before Tax | 44.46% | 67.27% | |||
| Income Tax Expenses | -142.86% | 133.33% | |||
| Earnings from Continuing Operations | 44.62% | 67.23% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 44.62% | 67.23% | |||
| EBIT | 14.40% | 30.05% | |||
| EBITDA | 14.44% | 30.59% | |||
| EPS Basic | 43.74% | 64.28% | |||
| Normalized Basic EPS | 84.88% | -90.46% | |||
| EPS Diluted | 43.74% | 64.28% | |||
| Normalized Diluted EPS | 84.88% | -90.46% | |||
| Average Basic Shares Outstanding | 10.87% | 2.49% | |||
| Average Diluted Shares Outstanding | 10.87% | 2.49% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
